Evidence map›Paper›PMID 41761094›Full record

ArticleBMC cardiovascular disorders2026

Feasibility and safety of right heart catheterization via median cubital vein in patients with pulmonary hypertension.

Yuxing Lai, Lingyun He, Han Cai, Wei Zhou, Jinzi Su, Pingping Wu, Zhoufei Fang

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuxing Lai *Department of Cardiology, Binhai Campus of the First Affiliated Hospital, National Regional Medical Center, Fujian Medical University, Fuzhou, Fujian, 350212, China.
Lingyun He *Department of Cardiology, Shaowu Municiple Hospital of Fujian Province, Ningping, Fujian, China.
Han CaiDepartment of Cardiology, Binhai Campus of the First Affiliated Hospital, National Regional Medical Center, Fujian Medical University, Fuzhou, Fujian, 350212, China.
Wei ZhouThe First Affiliated Hospital, Fujian Hypertension Research Institute, Fujian Medical University, Fuzhou, Fujian, China.
Jinzi SuDepartment of Cardiology, Binhai Campus of the First Affiliated Hospital, National Regional Medical Center, Fujian Medical University, Fuzhou, Fujian, 350212, China.
Pingping Wu *Department of General Practice, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China. 441223340@qq.com.
Zhoufei Fang *Department of Geriatrics, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China. 64967607@qq.com.

Funding

(5)Science and Technology Innovation Joint Fund Project of Nanping, Fujian Province. Efficacy and Mechanism Exploration of Pulmonary Vein Isolation Combined with Renal Denervation in the Treatment of Persistent Atrial Fibrillation Complicated with Refractory Hypertension. N2024LH035.Fujian Natural Science Foundation project，Fujian Province science and technology innovation joint fund project， 2024J01516.2024Y9177.Fujian Province science and technology innovation joint fund project，Fujian Natural Science Foundation project， 2023Y9067.2024J0558.Fujian Provincial Health and Wellness Science and Technology Project. Study on the Optimal Intervention Time and Therapeutic Mechanism of Pulmonary Artery Denervation for Wild Lily Alkaloid-Induced Pulmonary Hypertension in Rats, 2025QNB012.Startup Fund for Scientific Research of Fujian Medical University No. 2023QH1103.
6 · The paper itself

Abstract

objectiveTo assess the feasibility and safety of right heart catheterization (RHC) via the cubital vein.

methodsThis retrospective-prospective cohort study included 93 patients (January 2020–June 2023) in the retrospective phase, with 48 undergoing cubital vein RHC (R-CV) and 45 femoral vein RHC (R-FV). A prospective phase (July 2023–October 2024) enrolled 60 patients, each undergoing both approaches. Subgroup analysis divided patients by right ventricular end-diastolic diameter (≥ 3.80 cm vs. <3.80 cm).

resultsR-CV showed fewer complications (8.89% vs. 0%, p = 0.028) and shorter fluoroscopy time (178.27 ± 43.27 s vs. 210.76 ± 54.80 s, p = 0.002) than R-FV. In patients with right ventricular dilation (≥ 3.80 cm), cubital vein RHC reduced fluoroscopy time compared to femoral vein RHC (p < 0.001).

conclusionCubital vein RHC is safe, efficient, and especially advantageous for patients with enlarged right ventricles, warranting wider adoption.

Indexed as

Cardiac CatheterizationCatheterization, PeripheralHypertension, PulmonaryAdultAgedFeasibility StudiesFemaleFemoral VeinHumansMaleMiddle AgedPuncturesRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsCubital veinPulmonary hypertensionRight heart catheterization

Identifiers

PMID41761094
PMCPMC13041055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.